Compounds > fanasil, pyrimethamine drug combination
Page last updated: 2024-08-24

fanasil, pyrimethamine drug combination and Toxoplasmosis, Ocular

fanasil, pyrimethamine drug combination has been researched along with Toxoplasmosis, Ocular in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Assouline, C; Ayoubi, JM; Berrébi, A; Bessières, MH; Cassaing, S; Lathière, M; Minville, V1
Bodaghi, B; Cassoux, N; Fardeau, C; Le Mer, Y; LeHoang, P; Lemaitre, C; Romand, S; Theaudin, M; Thulliez, P1
Binquet, C; Denis, P; Fleury, J; Garweg, JG; Kodjikian, L; Peyron, F; Wallon, M1
Havlíková, M; Michalová, K; Ríhová, E1
Comte, P; Le Bras, M; Verin, P1

Trials

1 trial(s) available for fanasil, pyrimethamine drug combination and Toxoplasmosis, Ocular

ArticleYear
[Treatment of recurrent congenital ocular toxoplasmosis. Our initial experience with Fansidar].
    Bulletin des societes d'ophtalmologie de France, 1989, Volume: 89, Issue:4

    Topics: Adolescent; Adult; Antimalarials; Child; Clinical Trials as Topic; Drug Combinations; Humans; Pyrimethamine; Recurrence; Sulfadoxine; Sulfanilamides; Time Factors; Toxoplasmosis, Ocular

1989

Other Studies

4 other study(ies) available for fanasil, pyrimethamine drug combination and Toxoplasmosis, Ocular

ArticleYear
Long-term outcome of children with congenital toxoplasmosis.
    American journal of obstetrics and gynecology, 2010, Volume: 203, Issue:6

    Topics: Age Factors; Child; Child Development; Child, Preschool; Chorioretinitis; Cohort Studies; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Monitoring, Physiologic; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyrimethamine; Risk Assessment; Spiramycin; Sulfadoxine; Time Factors; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular

2010
[Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
    Journal francais d'ophtalmologie, 2003, Volume: 26, Issue:9

    Topics: Adolescent; Adult; Aged; Algorithms; Anti-Inflammatory Agents; Antiprotozoal Agents; Azithromycin; Chorioretinitis; Clindamycin; Decision Trees; Diagnosis, Differential; Drug Combinations; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Male; Middle Aged; Paracentesis; Polymerase Chain Reaction; Pyrimethamine; Retrospective Studies; Sulfadoxine; Toxoplasmosis, Ocular; Treatment Outcome

2003
Ocular manifestations in congenital toxoplasmosis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2006, Volume: 244, Issue:1

    Topics: Adolescent; Adult; Antibodies, Protozoan; Antiprotozoal Agents; Child; Child, Preschool; Chorioretinitis; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Male; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular; Vision Disorders

2006
[Fansidar in the treatment of toxoplasmosis].
    Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti, 1996, Volume: 52, Issue:3

    Topics: Adolescent; Adult; Antiprotozoal Agents; Drug Combinations; Humans; Middle Aged; Pyrimethamine; Retrospective Studies; Sulfadoxine; Toxoplasmosis, Ocular

1996